一个案例系列的氧化激素加剧了皮肤肌炎皮疹
Katelyn Rypka1, Michele Buonomo, Connor Buechler
1University of Minnesota Medical School, Minneapolis, Minnesota, USA Department of Dermatology, Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.
Dermatology online journal
|March 13, 2024
概括
氧化 (HCQ) 可以使皮肤肌肉炎 (DM) 的皮肤症状在某些患者中恶化. 停止使用HCQ可能会导致皮肤疾病的改善,这表明HCQ和DM恶化之间存在潜在联系.
科学领域:
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化 (HCQ) 是一种广泛用于风湿性皮肤疾病的抗疟疾药物.
- 关于HCQ诱导的皮肤肌炎 (DM) 恶化的证据有限.
研究的目的:
- 调查氧化 (HCQ) 使用与皮肤肌肉炎 (DM) 的恶化之间的关联.
- 报告DM患者的临床发现和结果,在HCQ启动后发生皮肤恶化.
主要方法:
- 一系列病例描述了三名患有皮肤肌炎 (DM) 的成年患者.
- 患者在启动氧化 (HCQ) 治疗后出现皮肤疾病恶化.
- 在停止HCQ后评估了结果.
主要成果:
- 这三名患者在HCQ启动后都出现了DM皮肤症状的恶化.
- 两名患者对转录中间因子1γ (TIF1γ) 产生了抗体;一名患者对抗NXP2产生了抗体.
- 停用HCQ导致皮肤症状在6周至6个月内改善或消失.
结论:
- 基 (HCQ) 可能与皮肤肌炎 (DM) 中皮肤特征的恶化有关.
- 在DM患者的皮肤病恶化或未能通过标准疗法改善的皮肤病患者中,应考虑停止使用HCQ.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Skin Diseases and Disorders
3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
245
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
245


